Clinical Pharmacy Services and Hospital Mortality Rates

We evaluated the associations between clinical pharmacy services and mortality rates in 1029 United States hospitals. A data base was constructed from Medicare mortality rates from the Health Care Financing Administration and the National Clinical Pharmacy Services data base. A multivariate regression analysis, controlling for severity of illness, was employed to determine the associations. Four clinical pharmacy services were associated with lower mortality rates: clinical research (p<0.0001), drug information (p=0.043), drug admission histories (p=0.005), and participation on a cardiopulmonary resuscitation (CPR) team (p=0.039). The actual number of deaths (lower) associated with the presence of these four services were clinical research 21,125 deaths in 108 hospitals, drug information 10,463 deaths in 237 hospitals, drug admission histories 3843 deaths in 30 hospitals, and CPR team participation 5047 deaths in 282 hospitals. This is the first study to indicate that both centrally based and patient‐specific clinical pharmacy services are associated with reduced hospital mortality rates. This suggests that these services save a significant number of lives in our nation's hospitals.

[1]  P. Rappaport Resource Book on Progressive Pharmaceutical Services , 1993 .

[2]  P. Kenkel Hospitals balk at mortality report results. , 1988, Modern healthcare.

[3]  F. Cammarata,et al.  Effect of pharmacists on health care outcomes in hospitalized patients. , 1993, American journal of hospital pharmacy.

[4]  C. Raehl,et al.  Pharmaceutical services in U.S. hospitals in 1989. , 1992, American journal of hospital pharmacy.

[5]  A. Rimm,et al.  Evaluation of the HCFA model for the analysis of mortality following hospitalization. , 1992, Health services research.

[6]  S. Rhee Factors Determining the Quality of Physician Performance in Patient Care , 1976, Medical care.

[7]  M. Mackay,et al.  Pharmacist monitoring of parenteral nutrition: clinical and cost effectiveness. , 1979, American journal of hospital pharmacy.

[8]  N. Laird,et al.  Incidence of adverse drug events and potential adverse drug events , 1995 .

[9]  V. Fuchs,et al.  Case Mix, Costs, and Outcomes: Differences Between Faculty and Community Services in a University Hospital , 1984 .

[10]  Mickey C. Smith,et al.  Handbook of institutional pharmacy practice , 1986 .

[11]  C. A. Bond,et al.  Role of the clinical pharmacist in improving drug therapy. Clinical pharmacists in outpatient therapy. , 1981, Archives of internal medicine.

[12]  D Draper,et al.  Hospital characteristics and quality of care. , 1992, JAMA.

[13]  B. Roberts,et al.  Pharmacist influence on economic and morbidity outcomes in a tertiary care teaching hospital. , 1997, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[14]  J. Mckenney,et al.  Effect of advanced pharmaceutical services on the incidence of adverse drug reactions. , 1979, American journal of hospital pharmacy.

[15]  C. Raehl,et al.  1992 National Clinical Pharmacy Services Study , 1994, Pharmacotherapy.

[16]  M. Pauly,et al.  Hospital output forecasts and the cost of empty hospital beds. , 1986, Health services research.

[17]  E. T. Herfindal,et al.  Effect of clinical pharmacy services on prescribing on an orthopedic unit. , 1983, American journal of hospital pharmacy.

[18]  C. A. Bond,et al.  The Impact of Clinical Pharmacists on Psychiatric Patients , 1996, Pharmacotherapy.

[19]  Watts Ca,et al.  The impact of case mix on hospital cost: a comparative analysis. , 1980 .

[20]  C. A. Bond,et al.  Sustained improvement in drug documentation, compliance, and disease control. A four-year analysis of an ambulatory care model. , 1984, Archives of internal medicine.

[21]  Stephen B. Soumerai,et al.  Improving Drug-Therapy Decisions through Educational Outreach , 1983 .

[22]  M. Speedie,et al.  Drug prescribing and its relation to length of hospital stay. , 1980, Inquiry : a journal of medical care organization, provision and financing.

[23]  Fluphenazine outpatient clinics: a pharmacist's role. , 1979 .

[24]  D. E. Miller,et al.  Establishing an aminoglycoside pharmacokinetic monitoring service in a community hospital. , 1981, American journal of hospital pharmacy.

[25]  E. Pedhazur Multiple Regression in Behavioral Research: Explanation and Prediction , 1982 .

[26]  C. Catizone,et al.  An Eleven-Year Review of the Pharmacy Literature: Documentation of the Value and Acceptance of Clinical Pharmacy , 1986, Drug intelligence & clinical pharmacy.

[27]  P Sharkey,et al.  The importance of severity of illness in assessing hospital mortality. , 1990, JAMA.

[28]  B. Dowd,et al.  The relationship of house staff experience to the cost and quality of inpatient care. , 1990, JAMA.

[29]  J. Avorn,et al.  Improving drug-therapy decisions through educational outreach. A randomized controlled trial of academically based "detailing". , 1983, The New England journal of medicine.

[30]  C. Hepler,et al.  Economic consequences of two drug-use control systems in a teaching hospital. , 1988, American journal of hospital pharmacy.

[31]  F J Hellinger,et al.  Physician and Hospital Factors Associated With Mortality of Surgical Patients , 1986, Medical care.

[32]  R. Elashoff,et al.  Flaws in mortality data. The hazards of ignoring comorbid disease. , 1988, JAMA.

[33]  C. Raehl,et al.  Hospital and Pharmacy Characteristics Associated With Mortality Rates in United States Hospitals , 1994, Pharmacotherapy.

[34]  C. Raehl,et al.  Hospital pharmacy services in the Great Lakes region. , 1990, American journal of hospital pharmacy.

[35]  S. Shortell,et al.  Effects of regulation, competition, and ownership on mortality rates among hospital inpatients. , 1988, The New England journal of medicine.

[36]  A A Rimm,et al.  Hospital characteristics and mortality rates. , 1989, The New England journal of medicine.

[37]  N. Wintfeld,et al.  Analyzing hospital mortality. The consequences of diversity in patient mix. , 1991, Journal of the American Medical Association (JAMA).

[38]  Bruce E. Wampold,et al.  Use of Multiple Regression in Counseling Psychology Research: A Flexible Data-Analytic Strategy. , 1987 .

[39]  J. Bauman,et al.  Influence of clinical pharmacist consultations on the use of drug blood level tests. , 1980, American journal of hospital pharmacy.

[40]  H. Hatoum,et al.  Effectiveness of clinical pharmacist interventions in a hemodialysis unit. , 1993, Clinical therapeutics.

[41]  C. Raehl,et al.  Health Care Professional Staffing, Hospital Characteristics, and Hospital Mortality Rates , 1999, Pharmacotherapy.

[42]  E. Nold,et al.  Use of clinical pharmacists to reduce cefamandole, cefoxitin, and ticarcillin costs. , 1982, American journal of hospital pharmacy.

[43]  M. Speedie,et al.  Relationship of inappropriate drug prescribing to increased length of hospital stay. , 1979, American journal of hospital pharmacy.

[44]  R H Brook,et al.  Adjusted hospital death rates: a potential screen for quality of medical care. , 1987, American journal of public health.

[45]  K. L. Kelly,et al.  The Impact of the Docent Clinical Pharmacist on Treatment of Streptococcal Pneumonia , 1982, Drug intelligence & clinical pharmacy.